V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008782 | 260012033 | 1.84 | 73.2 | null | 2018-06-10 | 2018-06-10 | Gemcitabine weekly | N | null | 260028600 | CVD |
| 260008783 | 260005815 | null | 67.7 | null | 2015-03-08 | 2015-03-12 | Rituximab | 99 | null | 260028602 | RITUXIMAB |
| 260008784 | 260005815 | 1.73 | 66.4 | Curative (C) | 2018-01-15 | 2018-01-24 | PACIFICO TRIAL | N | N | 260028602 | CARBOPLATIN + ETOPOSIDE |
| 260008785 | 260005815 | 1.75 | null | Curative (C) | 2018-03-04 | 2018-03-10 | CVP R + GEMCITABINE | N | N | 260028602 | IRINOTECAN + MDG |
| 260008786 | 260005816 | 1.7 | 0 | Not known (9) | 2018-06-08 | 2018-06-08 | R Chlorambucil | N | null | 260028605 | RITUXIMAB |
| 260008787 | 260005816 | 1.7 | 77.4 | Disease modification (D) | 2016-05-08 | 2016-06-10 | Rituximab | N | N | 260028605 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008788 | 260005817 | 1.71 | 111 | Curative (C) | 2013-07-17 | 2013-07-29 | ABVD | N | N | 260028609 | GALLIUM TRIAL |
| 260008789 | 260005818 | 1.61 | 85.85 | Adjuvant (A) | 2014-05-26 | 2014-05-29 | Gemcitabine weekly | N | N | 260028610 | RITUXIMAB |
| 260008790 | 260012036 | 1.72 | 70.8 | Curative (C) | 2016-06-18 | 2016-07-01 | CYCLOPHOSPHAMIDE + ETOPOSIDE | 2 | N | 260028612 | GALLIUM TRIAL |
| 260008791 | 260012036 | 1.69 | 90 | Curative (C) | 2013-02-22 | 2013-03-01 | CHLORAMBUCIL + RITUXIMAB | 2 | N | 260028612 | EOX |
| 260008792 | 260017410 | 1.61 | 48.9 | Palliative (P) | 2016-04-16 | 2016-05-08 | Cisplatin + Radiotherapy | N | N | 260028621 | CHLORAMBUCIL |
| 260008793 | 260005819 | 1.79 | 79 | Adjuvant (A) | 2017-09-09 | 2017-10-05 | LEAM | N | Y | 260028622 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260008794 | 260012037 | 1.74 | 75 | Disease modification (D) | 2015-04-19 | 2017-01-10 | Bendamustine +/- Prednisolone | 02 | N | 260028623 | ICE-R |
| 260008795 | 260005820 | 1.76 | 80.5 | Curative (C) | 2015-09-25 | 2015-10-07 | Rituximab | 02 | N | 260028624 | BENDAMUSTINE |
| 260008796 | 260005821 | 1.84 | 78.2 | null | 2017-09-18 | 2017-09-24 | Rituximab | 2 | N | 260028629 | DOCETAXEL |
| 260008797 | 260005821 | 1.72 | 73.5 | Curative (C) | 2018-04-06 | 2018-04-06 | CISPLATIN + GEMCITABINE | N | N | 260028629 | CHOP R + METHOTREXATE |
| 260008798 | 260005822 | null | 62.3 | Palliative (P) | 2016-04-16 | 2016-04-16 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260028632 | RITUXIMAB |
| 260008799 | 260005822 | null | 79.4 | Adjuvant (A) | null | 2013-05-12 | CISPLATIN + ETOPOSIDE | N | null | 260028632 | GALLIUM TRIAL |
| 260008800 | 260005822 | 1.65 | 66.3 | Palliative (P) | 2017-06-13 | 2017-06-22 | Rituximab | N | N | 260028632 | ICE-R |
| 260008801 | 260005823 | null | 66 | Neo-adjuvant (N) | 2017-02-10 | 2017-02-17 | Rituximab (Maintenance) | N | N | 260028636 | RITUXIMAB |
| 260008802 | 260005823 | 1.73 | 121 | Curative (C) | 2015-12-08 | 2015-12-10 | BEAM | 02 | Y | 260028636 | CISPLATIN + ETOPOSIDE |
| 260008803 | 260005823 | 1.55 | 66.3 | Curative (C) | 2017-07-20 | 2017-07-23 | CHOP - 21 days | Y | N | 260028636 | CARBOPLATIN + VINORELBINE |
| 260008804 | 260005823 | 1.74 | null | Palliative (P) | 2015-09-14 | 2015-09-20 | PACIFICO TRIAL | N | N | 260028636 | CVD |
| 260008805 | 260005824 | 1.9 | 85.4 | Curative (C) | 2015-06-20 | 2015-07-17 | Rituximab | 2 | N | 260028641 | RITUXIMAB |
| 260008806 | 260012041 | 1.79 | null | Palliative (P) | 2015-05-02 | 2015-05-07 | Cyclophosphamide + Vincristine | N | N | 260028644 | RITUXIMAB |
| 260008807 | 260012041 | null | 89.1 | Curative (C) | 2017-04-11 | 2017-04-18 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | Y | 260028644 | CAPECITABINE + OXALIPLATIN |
| 260008808 | 260005825 | 1.88 | 66 | Curative (C) | 2014-11-06 | 2014-11-07 | Cisplatin + Etoposide (5 day) | 99 | null | 260028646 | CISPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260008809 | 260005825 | 1.74 | 130 | Curative (C) | 2016-01-13 | 2016-02-03 | Azacitidine | N | N | 260028646 | RITUXIMAB |
| 260008810 | 260005826 | null | null | null | null | 2015-08-02 | Rituximab | N | null | 260028649 | FCR |
| 260008811 | 260005827 | 1.64 | null | Disease modification (D) | 2014-09-18 | 2014-09-25 | Rituximab | N | N | 260028651 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008812 | 260005828 | 1.67 | 64.8 | Palliative (P) | 2015-11-06 | 2015-11-10 | null | N | N | 260028652 | TRIAL |
| 260008813 | 260005829 | 1.54 | 65.7 | Palliative (P) | 2014-05-25 | 2014-06-08 | Rituximab | N | N | 260028654 | RITUXIMAB |
| 260008814 | 260005830 | 1.65 | 52.9 | Curative (C) | 2013-06-16 | 2013-06-30 | CYCLOPHOSPHAMIDE | N | N | 260028655 | RITUXIMAB |
| 260008815 | 260005830 | 1.64 | 77 | Not known (9) | 2014-04-27 | 2014-05-03 | Rituximab | N | N | 260028655 | RITUXIMAB |
| 260008816 | 260005830 | 1.86 | 0 | Curative (C) | 2017-06-15 | 2017-06-27 | ABVD | 2 | N | 260028655 | RITUXIMAB |
| 260008817 | 260005831 | 1.73 | 80.5 | null | null | 2017-05-04 | PEMBROLIZUMAB | null | null | 260028658 | TRIAL |
| 260008818 | 260005831 | 1.74 | 94 | Adjuvant (A) | 2014-08-15 | 2015-03-14 | Capecitabine + Oxaliplatin 21day | N | N | 260028658 | FLUOROURACIL |
| 260008819 | 260005832 | 1.67 | 112.4 | null | 2016-02-06 | 2016-02-08 | GEFITINIB | Y | N | 260028663 | RITUXIMAB |
| 260008820 | 260005832 | 1.81 | 108 | Curative (C) | 2013-06-24 | 2013-07-16 | CISPLATIN + ETOPOSIDE | N | N | 260028663 | CARBOPLATIN + ETOPOSIDE |
| 260008821 | 260005833 | 1.8 | 106.4 | Disease modification (D) | 2013-09-11 | 2013-09-19 | CHOP - 21 days | 2 | N | 260028671 | RITUXIMAB |
| 260008822 | 260005833 | 1.51 | 71.55 | Disease modification (D) | 2017-12-01 | 2017-12-01 | GALLIUM TRIAL | N | N | 260028671 | RITUXIMAB |
| 260008823 | 260005834 | 1.77 | null | Curative (C) | 2014-08-12 | 2014-08-14 | Rituximab | 02 | N | 260028677 | ABVD |
| 260008824 | 260012047 | 1.8 | 69.2 | null | 2014-07-07 | 2014-07-13 | CHOP - 21 days | N | N | 260028681 | RITUXIMAB |
| 260008825 | 260005835 | 1.81 | 78.6 | Palliative (P) | 2017-07-31 | 2017-08-06 | CHOP R + METHOTREXATE | 02 | N | 260028686 | CHOP |
| 260008826 | 260012048 | 1.56 | 50.3 | Disease modification (D) | 2017-08-27 | 2017-08-28 | CISPLATIN + RT | 2 | N | 260028687 | RITUXIMAB |
| 260008827 | 260015570 | 1.72 | 72.3 | Palliative (P) | 2016-11-03 | 2016-11-04 | Rituximab | 02 | N | 260028688 | RITUXIMAB |
| 260008828 | 260017412 | 1.83 | null | Adjuvant (A) | 2013-03-13 | 2013-03-13 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260028690 | FCR |
| 260008829 | 260005836 | null | 60 | null | 2017-04-17 | 2017-04-25 | Cisplatin + Radiotherapy | null | null | 260028694 | CISPLATIN + PACLITAXEL |
| 260008830 | 260005836 | 1.59 | 68.3 | Curative (C) | 2016-06-04 | 2016-06-13 | null | N | N | 260028694 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008831 | 260005836 | 1.74 | 67.3 | Disease modification (D) | 2017-02-15 | 2017-02-21 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | 02 | N | 260028694 | RITUXIMAB |